[TLX] QoQ Quarter Result on 31-Jan-2017 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Jan-2017
Financial Year
2016
Quarter
31-Jan-2017 [#Q4]
Profit Trend
QoQ- -202.91%
YoY- -2,257.58%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 CAGR
Revenue 0 49 0 0 0 0 0 -
PBT -5,190 -4,806 -3,143 -1,594 1,550 -66 -66 327.85%
Tax -5,190 -471 -76 -38 24 -8 -8 763.98%
NP -5,190 -4,806 -3,143 -1,556 1,512 -66 -66 327.85%
Tax Rate - - - - -1.54% - - -
Total Cost 5,190 4,854 3,143 1,556 -1,512 66 66 327.85%
Ratio Analysis
30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 CAGR
NP Margin 0.00 -9,850.62 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 CAGR
EPS -0.03 -0.02 -1.28 -0.01 0.01 0.00 0.00 -
EPS Diluted -0.03 -0.02 -1.28 -0.01 0.01 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.